Our 12 month study using
with remote monitoring
We wanted to show that patients-at-home using TrackMyTac to manage their daily Tacrolimus dosing will have better dose adherence with reduced volatility and improved physician reporting
25 patients used TMT daily for 12 months to help coach dose adherence and provide monthly physician reporting using remote monitoring
A group of 25 similar patients' Tac readings were used as a comparator
Our study was carried out between October 2020 and November 2021 in difficult circumstances, during a period of prolonged Covid lock-downs
The charted results show clearly that TMT-patient Tac levels (2nd chart) have much lower 1-year variability than those from the comparison group
For more about TMT's remote monitoring and reporting, click here.